Search research articles
Contact Us
Filters
Showing results (391-400 of 449) with videos related to
Page
of 45
Sort By:
EJNMMI Research
|
August 18, 2017
A human PET study of [<sup>11</sup>C]HMS011, a potential radioligand for AMPA receptors
Keisuke Takahata, Yasuyuki Kimura, Chie Seki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 26, 2014
Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology
Hiroki Hashimoto, Kazunori Kawamura, Nobuyuki Igarashi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 3, 2016
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors
Bin Ji, Hiroyuki Kaneko, Takafumi Minamimoto, et al.
Annals of Neurology
|
September 13, 2023
Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease
Kosei Hirata, Kiwamu Matsuoka, Kenji Tagai, et al.
The International Journal of Neuropsychopharmacology
|
December 19, 2013
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂
Harumasa Takano, Ryosuke Arakawa, Tsuyoshi Nogami, et al.
Translational Psychiatry
|
October 2, 2024
Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder
Yasunori Sano, Yasuharu Yamamoto, Manabu Kubota, et al.
Neuroimage
|
November 25, 2022
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607)
Kenji Tagai, Yoko Ikoma, Hironobu Endo, et al.
Brain : a Journal of Neurology
|
January 15, 2017
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
Maiko Ono, Naruhiko Sahara, Katsushi Kumata, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 8, 2020
Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[<sup>11</sup>C]methoxyphenethyl)pyridazin-3(2H)-one, a <sup>11</sup>C-labeled d-amino acid oxidase (DAAO) inhibitor for PET imaging
Xiaoyun Deng, Yiding Zhang, Zhen Chen, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation
Yuxuan Wu, Xingkai Wang, Xiaona Sun, et al.
Page
of 45
Search research articles
Search
Showing results (391-400 of 449) with videos related to
Sort By:
Page
of 45
EJNMMI Research
|
August 18, 2017
A human PET study of [<sup>11</sup>C]HMS011, a potential radioligand for AMPA receptors
Keisuke Takahata, Yasuyuki Kimura, Chie Seki, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 26, 2014
Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology
Hiroki Hashimoto, Kazunori Kawamura, Nobuyuki Igarashi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
December 3, 2016
Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors
Bin Ji, Hiroyuki Kaneko, Takafumi Minamimoto, et al.
Annals of Neurology
|
September 13, 2023
Altered Brain Energy Metabolism Related to Astrocytes in Alzheimer's Disease
Kosei Hirata, Kiwamu Matsuoka, Kenji Tagai, et al.
The International Journal of Neuropsychopharmacology
|
December 19, 2013
Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂
Harumasa Takano, Ryosuke Arakawa, Tsuyoshi Nogami, et al.
Translational Psychiatry
|
October 2, 2024
Alterations of striatal phosphodiesterase 10 A and their association with recurrence rate in bipolar I disorder
Yasunori Sano, Yasuharu Yamamoto, Manabu Kubota, et al.
Neuroimage
|
November 25, 2022
An optimized reference tissue method for quantification of tau protein depositions in diverse neurodegenerative disorders by PET with <sup>18</sup>F-PM-PBB3 (<sup>18</sup>F-APN-1607)
Kenji Tagai, Yoko Ikoma, Hironobu Endo, et al.
Brain : a Journal of Neurology
|
January 15, 2017
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
Maiko Ono, Naruhiko Sahara, Katsushi Kumata, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 8, 2020
Synthesis and preliminary evaluation of 4-hydroxy-6-(3-[<sup>11</sup>C]methoxyphenethyl)pyridazin-3(2H)-one, a <sup>11</sup>C-labeled d-amino acid oxidase (DAAO) inhibitor for PET imaging
Xiaoyun Deng, Yiding Zhang, Zhen Chen, et al.
Acta Pharmaceutica Sinica. B
|
October 6, 2025
Fibroblast activation protein targeting radiopharmaceuticals: From drug design to clinical translation
Yuxuan Wu, Xingkai Wang, Xiaona Sun, et al.
Page
of 45